Clinical trials
Phase 3 Prostatic Hyperplasia trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2019 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Not yet recruiting | 2 |
| Terminated | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Manitoba | 3 |
| AEterna Zentaris | 2 |
| Eli Lilly and Company | 2 |
| CMX Research | 1 |
| Dr. J. Curtis Nickel | 1 |
| GlaxoSmithKline | 1 |
| Sanofi | 1 |
| Sophiris Bio Corp | 1 |
| University of Alberta | 1 |
| Urovant Sciences GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 14 |
| Erectile Dysfunction | 1 |
| Lower Urinary Tract Symptoms | 1 |
| Prostatic Neoplasms | 1 |
| Urinary Bladder, Overactive | 1 |
| Urinary Retention | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.